Tokyo Tape
Sign in
← Cuc

Annual report

9158.TEDINET S100TWCD
Period2023-04-01 → 2024-03-31
Filed2024-06-27
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 132
MetricValuePeriodScopeSource row
Revenue¥33.0bn2023-04-01 → 2024-03-31Cons.Revenue IFRS
Revenue¥35.2bn2022-04-01 → 2023-03-31Cons.Revenue IFRS
Revenue¥35.3bn2021-04-01 → 2022-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥16.6bn2020-04-01 → 2021-03-31dCons.Revenue IFRS (5-year summary)
Operating income¥3.7bn2023-04-01 → 2024-03-31Cons.Operating profit loss IFRS
Operating income¥3.7bn2022-04-01 → 2023-03-31Cons.Operating profit loss IFRS
Profit before tax¥4.1bn2023-04-01 → 2024-03-31Cons.Profit loss before tax IFRS
Profit before tax¥3.6bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS
Profit before tax¥3.6bn2021-04-01 → 2022-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥1.6bn2020-04-01 → 2021-03-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥2.6bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥2.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥2.7bn2021-04-01 → 2022-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥1.1bn2020-04-01 → 2021-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥2.6bn2023-04-01 → 2024-03-31Cons.Profit loss IFRS
Net income¥2.4bn2022-04-01 → 2023-03-31Cons.Profit loss IFRS
Total assets¥62.8bnat 2024-03-31Cons.Assets IFRS
Total assets¥39.8bnat 2023-03-31Cons.Assets IFRS
Total assets¥34.5bnat 2022-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥28.4bnat 2021-03-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥34.8bnat 2024-03-31Cons.Liabilities IFRS
Total liabilities¥27.8bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥28.0bnat 2024-03-31Cons.Equity IFRS
Net assets / equity¥11.9bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥9.7bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥27.3bnat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥11.7bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥9.5bnat 2022-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥4.7bnat 2021-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥8.3bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥4.1bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥4.4bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥3.6bnat 2021-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥4.2bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥2.4bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥6.6bn2021-04-01 → 2022-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥2.1bn2020-04-01 → 2021-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥14.7bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥6.7bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥1.5bn2021-04-01 → 2022-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥2.4bn2020-04-01 → 2021-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow¥14.4bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥4.0bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥4.4bn2021-04-01 → 2022-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥591m2020-04-01 → 2021-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥93.992023-04-01 → 2024-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥113.92022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥129.682021-04-01 → 2022-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥52.712020-04-01 → 2021-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥93.992023-04-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥113.92022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥129.682021-04-01 → 2022-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥52.712020-04-01 → 2021-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥931.79at 2024-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥533.1at 2023-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥453.12at 2022-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥226.83at 2021-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio43.5%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio29.4%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio27.4%at 2022-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio16.6%at 2021-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE13.3%2023-04-01 → 2024-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE22.9%2022-04-01 → 2023-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE38.1%2021-04-01 → 2022-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE27.1%2020-04-01 → 2021-03-31dCons.Rate of return on equity IFRS (5-year summary)
Employees3,743at 2024-03-31Cons.Number of employees
Employees2,994at 2023-03-31Cons.Number of employees
Employees2,470at 2022-03-31dCons.Number of employees
Employees1,819at 2021-03-31dCons.Number of employees
Revenue¥7.8bn2023-04-01 → 2024-03-31StandaloneNet sales
Revenue¥14.3bn2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥15.4bn2021-04-01 → 2022-03-31dStandaloneNet sales (5-year summary)
Revenue¥4.0bn2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Revenue¥3.8bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Operating income¥2.2bn2023-04-01 → 2024-03-31StandaloneOperating income
Operating income¥1.9bn2022-04-01 → 2023-03-31StandaloneOperating income
Ordinary income¥1.9bn2023-04-01 → 2024-03-31StandaloneOrdinary income
Ordinary income¥1.8bn2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income¥2.4bn2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥795m2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥312m2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥1.9bn2023-04-01 → 2024-03-31StandaloneIncome before income taxes
Profit before tax¥1.8bn2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Net income¥1.3bn2023-04-01 → 2024-03-31StandaloneProfit loss
Net income¥1.3bn2022-04-01 → 2023-03-31StandaloneProfit loss
Net income¥1.7bn2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Net income¥574m2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income¥122m2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Total assets¥45.5bnat 2024-03-31StandaloneAssets
Total assets¥28.4bnat 2023-03-31StandaloneAssets
Total assets¥23.9bnat 2022-03-31dStandaloneTotal assets (5-year summary)
Total assets¥19.4bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥18.6bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥23.2bnat 2024-03-31StandaloneLiabilities
Total liabilities¥20.3bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥22.3bnat 2024-03-31StandaloneNet assets
Net assets / equity¥8.1bnat 2023-03-31StandaloneNet assets
Net assets / equity¥7.4bnat 2022-03-31dStandaloneNet assets
Net assets / equity¥3.9bnat 2021-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥3.3bnat 2020-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥3.4bnat 2024-03-31StandaloneCash and deposits
Cash and deposits¥554mat 2023-03-31StandaloneCash and deposits
EPS (basic)¥46.012023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥60.212022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥78.532021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥25.982020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥1,145.52019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥759.3at 2024-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥365.69at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥335.57at 2022-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥176.49at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥30,101.95at 2020-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio48.8%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio28.4%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio30.9%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio20.1%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio17.9%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE8.4%2023-04-01 → 2024-03-31StandaloneRate of return on equity (5-year summary)
ROE16.6%2022-04-01 → 2023-03-31StandaloneRate of return on equity (5-year summary)
ROE30.6%2021-04-01 → 2022-03-31dStandaloneRate of return on equity (5-year summary)
ROE15.9%2020-04-01 → 2021-03-31dStandaloneRate of return on equity (5-year summary)
ROE5.4%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued29,990,400at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued113,152at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued104,352at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued104,352at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued104,352at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees434at 2024-03-31StandaloneNumber of employees
Employees423at 2023-03-31StandaloneNumber of employees
Employees374at 2022-03-31dStandaloneNumber of employees
Employees304at 2021-03-31dStandaloneNumber of employees
Employees310at 2020-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 55
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2024-03-315 pure
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2024-03-31¥205m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2024-03-31¥205m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2024-03-31¥18m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2024-03-31−¥696m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2024-03-31−¥696m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2024-03-31−¥1.2bn
Hospicereportable segmentemployeesat 2024-03-311391 pure
Hospicereportable segmentrevenue2023-04-01 → 2024-03-31¥10.4bn
Hospicereportable segmentrevenue external2023-04-01 → 2024-03-31¥10.4bn
Hospicereportable segmentrevenue intersegment2023-04-01 → 2024-03-31¥1m
Hospicereportable segmentsegment profit2023-04-01 → 2024-03-31¥349m
In Home Nursingreportable segmentemployeesat 2024-03-311455 pure
In Home Nursingreportable segmentrevenue2023-04-01 → 2024-03-31¥10.9bn
In Home Nursingreportable segmentrevenue external2023-04-01 → 2024-03-31¥10.9bn
In Home Nursingreportable segmentrevenue intersegment2023-04-01 → 2024-03-31¥0
In Home Nursingreportable segmentsegment profit2023-04-01 → 2024-03-31¥616m
Medical Institutionreportable segmentemployeesat 2024-03-31808 pure
Medical Institutionreportable segmentrevenue2023-04-01 → 2024-03-31¥12.2bn
Medical Institutionreportable segmentrevenue external2023-04-01 → 2024-03-31¥11.5bn
Medical Institutionreportable segmentrevenue intersegment2023-04-01 → 2024-03-31¥695m
Medical Institutionreportable segmentsegment profit2023-04-01 → 2024-03-31¥3.9bn
—segment totalrevenue2023-04-01 → 2024-03-31¥33.5bn
—segment totalrevenue external2023-04-01 → 2024-03-31¥32.8bn
—segment totalrevenue intersegment2023-04-01 → 2024-03-31¥696m
—segment totalsegment profit2023-04-01 → 2024-03-31¥4.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2024-03-31¥33.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2024-03-31¥33.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2024-03-31¥696m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2024-03-31¥4.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2023-03-31¥205m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2023-03-31¥205m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2023-03-31¥29m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2023-03-31−¥263m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2023-03-31−¥263m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2023-03-31−¥843m
Hospicereportable segmentrevenue2022-04-01 → 2023-03-31¥6.6bn
Hospicereportable segmentrevenue external2022-04-01 → 2023-03-31¥6.6bn
Hospicereportable segmentsegment profit2022-04-01 → 2023-03-31¥191m
In Home Nursingreportable segmentrevenue2022-04-01 → 2023-03-31¥12.2bn
In Home Nursingreportable segmentrevenue external2022-04-01 → 2023-03-31¥12.2bn
In Home Nursingreportable segmentsegment profit2022-04-01 → 2023-03-31¥1.4bn
Medical Institutionreportable segmentrevenue2022-04-01 → 2023-03-31¥16.4bn
Medical Institutionreportable segmentrevenue external2022-04-01 → 2023-03-31¥16.2bn
Medical Institutionreportable segmentrevenue intersegment2022-04-01 → 2023-03-31¥263m
Medical Institutionreportable segmentsegment profit2022-04-01 → 2023-03-31¥3.0bn
—segment totalrevenue2022-04-01 → 2023-03-31¥35.3bn
—segment totalrevenue external2022-04-01 → 2023-03-31¥35.0bn
—segment totalrevenue intersegment2022-04-01 → 2023-03-31¥263m
—segment totalsegment profit2022-04-01 → 2023-03-31¥4.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2023-03-31¥35.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2023-03-31¥35.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2023-03-31¥263m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2023-03-31¥4.5bn
Medical Institutionreportable segmentemployeesat 2024-03-31350 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,678
ItemContextValueUnit
Customer lists IFRSCurrentYearInstant4250000000JPY
Other components of intangible assets IFRSCurrentYearInstant64000000JPY
Goodwill and intangible assets IFRSCurrentYearInstant4420000000JPY
Employee benefit expenses cos IFRSPrior1YearDuration13071000000JPY
Employee benefit expenses cos IFRSCurrentYearDuration15711000000JPY
Outsourcing expenses cos IFRSPrior1YearDuration7376000000JPY
Outsourcing expenses cos IFRSCurrentYearDuration15000000JPY
Other cos IFRSPrior1YearDuration987000000JPY
Other cos IFRSCurrentYearDuration1376000000JPY
Cost of sales IFRSPrior1YearDuration21434000000JPY
Cost of sales IFRSCurrentYearDuration17102000000JPY
Employee benefit expenses sga IFRSPrior1YearDuration3438000000JPY
Employee benefit expenses sga IFRSCurrentYearDuration4453000000JPY
Depreciation and amortization sga IFRSPrior1YearDuration1220000000JPY
Depreciation and amortization sga IFRSCurrentYearDuration1803000000JPY
Commission expenses sga IFRSPrior1YearDuration1950000000JPY
Commission expenses sga IFRSCurrentYearDuration2147000000JPY
Recruitment and training expence selling general and administrative expenses IFRSPrior1YearDuration1157000000JPY
Recruitment and training expence selling general and administrative expenses IFRSCurrentYearDuration1140000000JPY
Taxes and dues sga IFRSPrior1YearDuration546000000JPY
Taxes and dues sga IFRSCurrentYearDuration570000000JPY
Tools furniture and fixtures selling general and administrative expenses IFRSPrior1YearDuration464000000JPY
Tools furniture and fixtures selling general and administrative expenses IFRSCurrentYearDuration468000000JPY
Traveling and transportation expenses sga IFRSPrior1YearDuration472000000JPY
Traveling and transportation expenses sga IFRSCurrentYearDuration659000000JPY
Other sga IFRSPrior1YearDuration769000000JPY
Other sga IFRSCurrentYearDuration966000000JPY
Selling general and administrative expenses IFRSPrior1YearDuration10015000000JPY
Selling general and administrative expenses IFRSCurrentYearDuration12206000000JPY
Gain on sale of property plant and equipment IFRSPrior1YearDuration1000000JPY
Gain on sale of property plant and equipment IFRSCurrentYearDuration1000000JPY
Miscellaneous income IFRSPrior1YearDuration44000000JPY
Miscellaneous income IFRSCurrentYearDuration63000000JPY
Other income IFRSPrior1YearDuration45000000JPY
Other income IFRSCurrentYearDuration64000000JPY
Losses on disposal of property plant and equipment and intangible assets IFRSPrior1YearDuration16000000JPY
Losses on disposal of property plant and equipment and intangible assets IFRSCurrentYearDuration3000000JPY
Loss on sale of property plant and equipment IFRSPrior1YearDuration8000000JPY
Loss on sale of property plant and equipment IFRSCurrentYearDuration－JPY
Provision of allowance for doubtful accounts other expenses IFRSPrior1YearDuration53000000JPY
Provision of allowance for doubtful accounts other expenses IFRSCurrentYearDuration－JPY
Other other expenses IFRSPrior1YearDuration46000000JPY
Other other expenses IFRSCurrentYearDuration42000000JPY
Other expenses IFRSPrior1YearDuration123000000JPY
Other expenses IFRSCurrentYearDuration45000000JPY
Interest income IFRSPrior1YearDuration50000000JPY
Interest income IFRSCurrentYearDuration28000000JPY
Financial assets measured at amortized cost interest income IFRSPrior1YearDuration50000000JPY
Financial assets measured at amortized cost interest income IFRSCurrentYearDuration28000000JPY
Foreign exchange gain IFRSPrior1YearDuration－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2024-03-31pass
balance sheet identitynon_consolidated 2023-03-31pass
balance sheet identitynon_consolidated 2024-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2024-03-31pass
statement vs summary · revenueconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenueconsolidated 2023-04-01/2024-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass